FOX 66 News at Ten
Story by Marilynn Marchione / ASSOCIATED PRESS
suggests that a shot every one to three months may someday give an
alternative to the daily pills that some people take now to cut their
risk of getting HIV.
The experimental drug has only been tested
for prevention in monkeys, but it completely protected them from
infection in two studies reported at an AIDS conference on Tuesday.
is the most exciting innovation in the field of HIV prevention that
I've heard recently," said Dr. Robert Grant, an AIDS expert at the
Gladstone Institutes, a foundation affiliated with the University of
California, San Francisco.
"Both groups are showing 100 percent
protection" with the drug, Grant said of the two groups of researchers.
"If it works and proves to be safe, it would allow for HIV to be
prevented with periodic injections, perhaps every three months."
a vaccine is developed, condoms are the best way to prevent infection
with the AIDS virus and many other sexually spread diseases. But not
everyone uses them, or does so all the time, so public health officials
have pursued other prevention options.
A drug used to treat
people with HIV — Gilead Science's Truvada — also is used to help
prevent infection in people who don't have the virus. A big study in gay
men a few years ago found it could cut this risk by up to 90 percent,
depending on how faithfully people take the daily pills.
research tested something that could make this type of prevention much
more practical — a long-acting experimental drug made by GlaxoSmithKline
PLC. The studies tested it in macaques exposed to a human-monkey
version of HIV.
Researchers at the Centers for Disease Control
and Prevention gave six monkeys shots of the drug every four weeks; six
others got dummy shots. All were exposed to the virus twice a week for
The monkeys who got the fake treatment were readily
infected "but the animals that received the long-acting drug remained
protected," said study leader Gerardo Garcia-Lerma of the CDC.
results mirror what was seen in the CDC's early research in monkeys on
Truvada, the pill that's available for HIV prevention now.
second study, Chasity Andrews and others at the Aaron Diamond AIDS
Research Center at Rockefeller University in New York gave eight monkeys
two shots of the drug, four weeks apart, and dummy shots to eight
others. The animals were exposed to the virus weekly for eight weeks.
Again, all animals given the fake treatment were quickly infected and
those on the drug were all protected.
To see how long a single
shot would last, they did a second study. The single shot protected 12
monkeys for about 10 weeks on average.
The dose used in a single shot corresponded to what people would get from a shot every three months, researchers said.
is really promising," said Dr. Judith Currier, an infectious disease
specialist at the University of California, Los Angeles. The research
"supports moving this forward" into human testing, she said.
is on the program committee for the meeting in Boston where the studies
were presented — the Conference on Retroviruses and Opportunistic
Infections. The New York study also was published online by the journal
Grant said the long-acting drug is chemically similar to
certain AIDS medicines sold now that are "extremely safe, well
tolerated and extremely potent." A mid-stage trial testing the
long-acting shots in people as a treatment, not a prevention, is already
underway, he said.
Wednesday, March 5 2014, 09:18 AM EST
National News Headlines
|Remains believed to be of missing Oklahoma teen|
|Remains found by a hunter this month in the rugged outback of southeast Oregon appear to be those of an Oklahoma teenager who went missing last year after telling his parents he wanted to test himself against the wilderness, like in the movie "Into the Wild."|
|Suspect arrested in fatal shooting of 2 California deputies, shooting of 2 others|
|A suspect was arrested Friday afternoon after two Northern California sheriff's deputies were killed during a series of shootings that spanned about six hours and 30 miles across two Northern California counties.|
|Referee for Major League Soccer suspended after New York arrest on fraud charge|
|A Major League Soccer referee has been accused of collecting New York unemployment benefits while working and has been suspended.|
|Cockroach disrupts Chicago City Hall during pest control chief's budget address|
|A cockroach embarrassed a Chicago official in charge of pest control when it took a stroll near him in full view of some aldermen, and its stunt just might have cost it and its buddies their lives.|
|California jury says castrated sex offender no longer sexually violent, should be released|
|A California jury has concluded that a castrated sex offender is no longer a sexually violent predator and is eligible for release from a mental hospital.|
|Hatchet attack on NYPD officers an act of terror, commissioner says|
|New York City police Commissioner William Bratton says the hatchet attack on four rookie officers was a terrorist act by a homegrown radical.|
|Gunman arrested after allegedly killing two California deputies, injuring another and bystander, arrested|
|A gunman who allegedly killed two sheriff's deputies and wounded another officer and a bystander in the Sacramento County area has been arrested, a spokeswoman for the Placer County sheriff said Friday night.|
|Report: Prosecutor won't file escape charges against Ohio school shooter who fled prison|
|An Ohio prosecutor has decided against filing charges against convicted high school shooter T.J.|
|Remains found in Virginia ID'd as those of Hannah Graham, police confirm|
|The Albemarle County Police Department confirmed Friday that remains discovered in a rural area last week are those of Hannah Graham, 18, the missing University of Virginia student.|
|Poll: 2 of 3 Americans think the threat posed by Islamic State is very important|
|Sixty-five percent of Americans now say the threat from the Islamic State group is very or even extremely important, and nearly half think the U.S. military response in Iraq and Syria has not gone far enough, according to an Associated Press-GfK poll.|